Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BRWD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM46D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMGN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SH3BGRL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBX22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITM2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR174 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
P2RY10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LPAR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZCCHC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POU3F4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYLC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on